Clinical Trials Sponsored by Liaoning Tumor Hospital & Institute

Total 178 results

Liaoning Tumor Hospital & Institute

Not yet recruiting

Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors

Breast Cancer
Liaoning Tumor Hospital & Institute

Not yet recruiting

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

NSCLC | EGF-R Positive Non-Small Cell Lung Cancer

China
Liaoning Tumor Hospital & Institute

Completed

Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer

China
Liaoning Tumor Hospital & Institute

Unknown

Irinotecan for Advanced and Metastatic Breast Cancer

Breast Cancer

China
Liaoning Tumor Hospital & Institute

Not yet recruiting

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Non Small Cell Lung Cancer
Liaoning Tumor Hospital & Institute

Not yet recruiting

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Diffuse Large B Cell Lymphoma

China
Liaoning Tumor Hospital & Institute

Not yet recruiting

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Triple-negative Breast Cancer
Liaoning Tumor Hospital & Institute

Not yet recruiting

Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method

China
Liaoning Tumor Hospital & Institute

Not yet recruiting

Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection

Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
Liaoning Tumor Hospital & Institute

Recruiting

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Advanced Breast Cancer

China
Liaoning Tumor Hospital & Institute

Completed

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Chemotherapy-induced Thrombocytopenia

China
Liaoning Tumor Hospital & Institute

Unknown

A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer

China
Liaoning Tumor Hospital & Institute

Unknown

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Colorectal Cancer | Liver Metastases

China
Yongpeng Wang

Recruiting

A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Ovarian Cancer

China
Zhang Rui

Recruiting

Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Rectal Cancer | Surgery | Almost-cCR

China
Shengjing Hospital
The People's Hospital of Liaoning Province; Liaoning Tumor Hospital & Institute

Recruiting

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Breast Cancer

China
Peking University
Zhejiang University; Liaoning Tumor Hospital & Institute

Active, not recruiting

Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

mCRC

China
Fudan University
Harbin Medical University; Liaoning Tumor Hospital & Institute

Unknown

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Adenocarcinoma | Neoadjuvant Therapy | Chemoradiotherapy | Rectal Neoplasm Malignant Carcinoma | Predictive Biomarkers

China
Liaoning Tumor Hospital & Institute
Huludao central hospital; Anshan Tumor Hospital; Chaoyang Central Hospital; Fukuang...

Not yet recruiting

AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer

Breast Neoplasm Female
Sun Yat-sen University
Fudan University; Liaoning Tumor Hospital & Institute

Active, not recruiting

PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer

Colorectal Carcinoma

China
China Medical University, China
Liaoning Tumor Hospital & Institute; The First People's Hospital of Jingzhou

Not yet recruiting

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaborators

Completed

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

Neoplasms

China
Tianjin Medical University Cancer Institute and...
Zhejiang Cancer Hospital; Fudan University; Liaoning Tumor Hospital & Institute; Gansu Cancer Hospital

Unknown

Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy

Soft Tissue Sarcoma, Adult, Stage II

China
Liaoning Tumor Hospital & Institute
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Not yet recruiting

Observational Study of Huaier Granules in Postoperative Adjuvant Therapy for Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Henan Cancer Hospital; Beijing Hospital; Jiangsu Cancer Institute & Hospital; Liaoning...

Completed

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Jilin Provincial Tumor Hospital; Hebei Medical University Fourth Hospital; Liaoning... and other collaborators

Unknown

A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer

Laryngeal Neoplasms | Malignant Neoplasm of Supraglottis Primary | Neck Dislocation

China
Guangzhou University of Traditional Chinese Medicine
Liaoning Tumor Hospital & Institute; Zhongshan People's Hospital, Guangdong... and other collaborators

Unknown

Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117 (PRISIT)

Occlusion and Stenosis of Unspecified Cerebral Artery
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; The People's... and other collaborators

Unknown

Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA

Metastatic Gastric Adenocarcinoma

China
Tianjin Medical University Cancer Institute and...
Fudan University; Shanghai Zhongshan Hospital; Harbin Medical University; Liaoning... and other collaborators

Unknown

Metformin Plus Sorafenib for Advanced HCC

Hepatocellular Carcinoma

China
Peking University People's Hospital
Hunan Cancer Hospital; Peking University Cancer Hospital & Institute; Peking... and other collaborators

Unknown

Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma (ALTER-S001)

Sarcoma

China
Tianjin Medical University Cancer Institute and...
Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaborators

Completed

Radiomics of Immunotherapeutics Response Evaluation and Prediction (RIREP)

Solid Tumor | Predictive Cancer Model

China
China Medical University, China
Shengjing Hospital; The People's Hospital of Liaoning Province; The First People... and other collaborators

Unknown

A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC

Non-small Cell Lung Cancer

China
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaborators

Unknown

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

Non Small Cell Lung Cancer
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaborators

Unknown

Endostar First-line Treatment of Advanced NSCLC

Non Small Cell Lung Cancer
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaborators

Unknown

Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

ColoRectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Sun Yat-sen University; Henan Cancer Hospital; Tongji... and other collaborators

Unknown

Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach

Esophageal Cancer

China
Chinese Academy of Sciences
Beijing Friendship Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaborators

Unknown

Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

Breast Cancer | Neoadjuvant Chemotherapy | Radiomics | Multi-parametric MRI

China
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Fujian Cancer Hospital; Henan Cancer Hospital; Tongji... and other collaborators

Unknown

Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement

Esophageal Cancer

China
Fudan University
Second Affiliated Hospital, School of Medicine, Zhejiang University; Ruijin... and other collaborators

Unknown

Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer (PHRAC)

Colorectal Neoplasms

China
Martini-Klinik am UKE GmbH
University Hospital Hamburg, Institute of Tumor Biology

Recruiting

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s) (ProsTone)

Prostate Cancer

Germany
Cancer Institute and Hospital, Chinese Academy...
Shanxi Province Cancer Hospital; Wuhan University; Peking Union Medical College... and other collaborators

Recruiting

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Breast Cancer Metastatic

China
China Medical University, China
The People's Hospital of Liaoning Province; The First Affiliated Hospital of... and other collaborators

Not yet recruiting

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Colorectal Neoplasms | Regorafenib | Raltitrexed | Third-line Treatment
Harbin Medical University
Sun Yat-sen University; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Colorectal Neoplasms | Chemotherapy

China
Harbin Medical University
Sun Yat-sen University; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Colorectal Neoplasms | Chemotherapy

China
Liaoning Tumor Hospital & Institute
China-Japan Friendship Hospital; First Hospital of China Medical University; Second... and other collaborators

Unknown

Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients (ALTER-S005)

Sarcoma, Soft Tissue

China
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Sun Yat-sen University; Shanghai Zhongshan Hospital; Fujian... and other collaborators

Unknown

Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy

Esophageal Cancer

China
St. Joseph's Hospital and Medical Center, Phoenix
Barrow Neurological Institute; Ivy Brain Tumor Center

Recruiting

Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) Participants With EGFR Alterations or Fusions

High Grade Glioma

United States
St. Joseph's Hospital and Medical Center, Phoenix
Barrow Neurological Institute; Ivy Brain Tumor Center

Completed

A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

Glioblastoma Multiforme | Glioma of Brain

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Morgagni Pierantoni Hospital

Completed

Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy

Breast Cancer

Italy
Tianjin Medical University Cancer Institute and...
Shanxi Province Cancer Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaborators

Recruiting

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) (KEYSTONE-002)

Esophageal Squamous Cell Carcinoma

China

Clinical Trials Sponsored by Liaoning Tumor Hospital & Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations